Profiling the lipid raft proteome from human MEC1 chronic lymphocytic Leukemia Cells

Journal of Proteomics and Bioinformatics

Volumn 7, Issue 4, 2014, Pages

  Alomari, Munther ^a   Mactier, Swetlana ^a   Kaufman, Kimberley L ^a   Best, O Giles ^b   Mulligan, Stephen P ^a,b   Christopherson, Richard I ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

Chronic lymphocytic leukemia; Immuno precipitation; Lipid raft; Mass spectrometry; Methyl cyclodextrin; Proteomics; Rituximab

Indexed keywords

ALEMTUZUMAB; CD20 ANTIGEN; PROTEOME; RITUXIMAB;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL VIABILITY; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; DENSITY GRADIENT CENTRIFUGATION; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOPRECIPITATION; LIPID RAFT; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 84899666603     PISSN: None     EISSN: 0974276X     Source Type: Journal    
DOI: 10.4172/jpb.S7-005     Document Type: Article

References (94)

1. Simons K, van Meer G (1988) Lipid sorting in epithelial cells. Biochemistry 27: 6197-6202.
2. Bodin S, Soulet C, Tronchère H, Sié P, Gachet C, et al. (2005) Integrindependent interaction of lipid rafts with the actin cytoskeleton in activated human platelets. J Cell Sci 118: 759-769.
3. Varma R, Mayor S (1998) GPI-anchored proteins are organized in submicron domains at the cell surface. Nature 394: 798-801.
4. Pike LJ (2006) Rafts defined: a report on the Keystone Symposium on Lipid Rafts and Cell Function. J Lipid Res 47: 1597-1598.
5. Lucero H, Gae D, Taccioli GE (2003) Novel localization of the DNA-PK complex in lipid rafts: a putative role in the signal transduction pathway of the ionizing radiation response. J Biol Chem 278: 22136-22143.
6. Baumann CA, Ribon V, Kanzaki M, Thurmond DC, Mora S, et al. (2000) CAP defines a second signalling pathway required for insulin-stimulated glucose transport. Nature 407: 202-207.
7. Cragg MS, Morgan SM, Chan HT, Morgan BP, Filatov AV, et al. (2003) Complement-mediated lysis by anti-CD20 mAb correlates with segregation into lipid rafts. Blood 101: 1045-1052.
8. Lucero HA, Robbins PW (2004) Lipid rafts-protein association and the regulation of protein activity. Arch Biochem Biophys 426: 208-224.
9. Stang E, Kartenbeck J, Parton RG (1997) Major histocompatibility complex class I molecules mediate association of SV40 with caveolae. Mol Biol Cell 8: 47-57.
10. Tran D, Carpentier JL, Sawano F, Gorden P, Orci L (1987) Ligands internalized through coated or noncoated invaginations follow a common intracellular pathway. Proc Natl Acad Sci U S A 84: 7957-7961.
11. Greicius G, Westerberg L, Davey EJ, Buentke E, Scheynius A, et al. (2004) Microvilli structures on B lymphocytes: inducible functional domains? Int Immunol 16: 353-364.
12. Staubach S, Hanisch FG (2011) Lipid rafts: signaling and sorting platforms of cells and their roles in cancer. Expert Rev Proteomics 8: 263-277.
13. Bang B, Gniadecki R, Gajkowska B (2005) Disruption of lipid rafts causes apoptotic cell death in HaCaT keratinocytes. Exp Dermatol 14: 266-272.
14. Li HY, Appelbaum FR, Willman CL, Zager RA, Banker DE (2003) Cholesterolmodulating agents kill acute myeloid leukemia cells and sensitize them to therapeutics by blocking adaptive cholesterol responses. Blood 101: 3628-3634.
15. Mineo C, James GL, Smart EJ, Anderson RG (1996) Localization of epidermal growth factor-stimulated Ras/Raf-1 interaction to caveolae membrane. J Biol Chem 271: 11930-11935.
16. Simons K, Toomre D (2000) Lipid rafts and signal transduction. Nat Rev Mol Cell Biol 1: 31-39.
17. Nel AE (2002) T-cell activation through the antigen receptor. Part 1: signaling components, signaling pathways, and signal integration at the T-cell antigen receptor synapse. J Allergy Clin Immunol 109: 758-770.
18. Patel HH, Murray F, Insel PA (2008) G-protein-coupled receptor-signaling components in membrane raft and caveolae microdomains. Handb Exp Pharmacol: 167-184.
19. Cahuzac N, Baum W, Kirkin V, Conchonaud F, Wawrezinieck L, et al. (2006) Fas ligand is localized to membrane rafts, where it displays increased cell death-inducing activity. Blood 107: 2384-2391.
20. Janas E, Priest R, Wilde JI, White JH, Malhotra R (2005) Rituxan (anti-CD20 antibody)-induced translocation of CD20 into lipid rafts is crucial for calcium influx and apoptosis. Clin Exp Immunol 139: 439-446.
21. Mone AP, Cheney C, Banks AL, Tridandapani S, Mehter N, et al. (2006) Alemtuzumab induces caspase-independent cell death in human chronic lymphocytic leukemia cells through a lipid raft-dependent mechanism. Leukemia 20: 272-279.
22. George KS, Wu S (2012) Lipid raft: A floating island of death or survival. Toxicol Appl Pharmacol 259: 311-319.
23. Foster LJ (2008) Lessons learned from lipid raft proteomics. Expert Rev Proteomics 5: 541-543.
24. Foster LJ, Chan QW (2007) Lipid raft proteomics: more than just detergentresistant membranes. Subcell Biochem 43: 35-47.
25. Subramaniam S, Fahy E, Gupta S, Sud M, Byrnes RW, et al. (2011) Bioinformatics and systems biology of the lipidome. Chem Rev 111: 6452-6490.
26. Baruthio F, Quadroni M, Rüegg C, Mariotti A (2008) Proteomic analysis of membrane rafts of melanoma cells identifies protein patterns characteristic of the tumor progression stage. Proteomics 8: 4733-4747.
27. Blonder J, Hale ML, Lucas DA, Schaefer CF, Yu LR, et al. (2004) Proteomic analysis of detergent-resistant membrane rafts. Electrophoresis 25: 1307-1318.
28. Yanagida M, Nakayama H, Yoshizaki F, Fujimura T, Takamori K, et al. (2007) Proteomic analysis of plasma membrane lipid rafts of HL-60 cells. Proteomics 7: 2398-2409.
29. Arielly SS, Ariel M, Yehuda R, Scigelova M, Yehezkel G, et al. (2012) Quantitative analysis of caveolin-rich lipid raft proteins from primary and metastatic colorectal cancer clones. J Proteomics 75: 2629-2637.
30. Foster LJ (2009) Moving closer to the lipid raft proteome using quantitative proteomics. Methods Mol Biol 528: 189-199.
31. Zheng YZ, Berg KB, Foster LJ (2009) Mitochondria do not contain lipid rafts, and lipid rafts do not contain mitochondrial proteins. J Lipid Res 50: 988-998.
32. Stacchini A, Aragno M, Vallario A, Alfarano A, Circosta P, et al. (1999) MEC1 and MEC2: two new cell lines derived from B-chronic lymphocytic leukaemia in prolymphocytoid transformation. Leuk Res 23: 127-136.
33. Gottardi D, Alfarano A, De Leo AM, Stacchini A, Aragno M, et al. (1996) In leukaemic CD5+ B cells the expression of BCL-2 gene family is shifted toward protection from apoptosis. Br J Haematol 94: 612-618.
34. Döhner H, Stilgenbauer S, Benner A, Leupolt E, Kröber A, et al. (2000) Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 343: 1910-1916.
35. Alfarano A, Indraccolo S, Circosta P, Minuzzo S, Vallario A, et al. (1999) An alternatively spliced form of CD79b gene may account for altered B-cell receptor expression in B-chronic lymphocytic leukemia. Blood 93: 2327-2335.
36. Natsume A, Shimizu-Yokoyama Y, Satoh M, Shitara K, Niwa R (2009) Engineered anti-CD20 antibodies with enhanced complement-activating capacity mediate potent anti-lymphoma activity. Cancer Sci 100: 2411-2418.
37. Brown DA, Rose JK (1992) Sorting of GPI-anchored proteins to glycolipidenriched membrane subdomains during transport to the apical cell surface. Cell 68: 533-544.
38. Mactier S, Henrich S, Che Y, Kohnke PL, Christopherson RI (2011) Comprehensive proteomic analysis of the effects of purine analogs on human Raji B-cell lymphoma. J Proteome Res 10: 1030-1042.
39. Jongstra-Bilen J, Wielowieyski A, Misener V, Jongstra J (1999) LSP1 regulates anti-IgM induced apoptosis in WEHI-231 cells and normal immature B-cells. Mol Immunol 36: 349-359.
40. Cao MY, Shinjo F, Heinrichs S, Soh JW, Jongstra-Bilen J, et al. (2001) Inhibition of anti-IgM-induced translocation of protein kinase C beta I inhibits ERK2 activation and increases apoptosis. J Biol Chem 276: 24506-24510.
41. Narita T, Nishimura T, Yoshizaki K, Taniyama T (2005) CIN85 associates with TNF receptor 1 via Src and modulates TNF-alpha-induced apoptosis. Exp Cell Res 304: 256-264.
42. Feng L, Wang JT, Jin H, Qian K, Geng JG (2011) SH3KBP1-binding protein 1 prevents epidermal growth factor receptor degradation by the interruption of c-Cbl-CIN85 complex. Cell Biochem Funct 29: 589-596.
43. Mizuchi D, Kurosu T, Kida A, Jin ZH, Jin A, et al. (2005) BCR/ABL activates Rap1 and B-Raf to stimulate the MEK/Erk signaling pathway in hematopoietic cells. Biochem Biophys Res Commun 326: 645-651.
44. Giguère PM, Laroche G, Oestreich EA, Siderovski DP (2012) G-protein signaling modulator-3 regulates heterotrimeric G-protein dynamics through dual association with Gβ and Gαi protein subunits. J Biol Chem 287: 4863-4874.
45. Luttrell LM (2008) Reviews in molecular biology and biotechnology: transmembrane signaling by G protein-coupled receptors. Mol Biotechnol 39: 239-264.
46. Gurevich VV, Gurevich EV (2008) Rich tapestry of G protein-coupled receptor signaling and regulatory mechanisms. Mol Pharmacol 74: 312-316.
47. Dorsam RT, Gutkind JS (2007) G-protein-coupled receptors and cancer. Nat Rev Cancer 7: 79-94.
48. Foster LJ, De Hoog CL, Mann M (2003) Unbiased quantitative proteomics of lipid rafts reveals high specificity for signaling factors. Proc Natl Acad Sci U S A 100: 5813-5818.
49. Hossain MN, Sakemura R, Fujii M, Ayusawa D (2006) G-protein gamma subunit GNG11 strongly regulates cellular senescence. Biochem Biophys Res Commun 351: 645-650.
50. Ridley AJ (2006) Rho GTPases and actin dynamics in membrane protrusions and vesicle trafficking. Trends Cell Biol 16: 522-529.
51. Boyer L, Magoc L, Dejardin S, Cappillino M, Paquette N, et al. (2011) Pathogenderived effectors trigger protective immunity via activation of the Rac2 enzyme and the IMD or Rip kinase signaling pathway. Immunity 35: 536-549.
52. Li B, Yu H, Zheng W, Voll R, Na S, et al. (2000) Role of the guanosine triphosphatase Rac2 in T helper 1 cell differentiation. Science 288: 2219-2222.
53. Reff ME, Carner K, Chambers KS, Chinn PC, Leonard JE, et al. (1994) Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20. Blood 83: 435-445.
54. Sun D, Xu D, Zhang B (2006) Rac signaling in tumorigenesis and as target for anticancer drug development. Drug Resist Updat 9: 274-287.
55. El Bekay R, Alba G, Reyes ME, Chacón P, Vega A, et al. (2007) Rac2 GTPase activation by angiotensin II is modulated by Ca2+/calcineurin and mitogenactivated protein kinases in human neutrophils. J Mol Endocrinol 39: 351-363.
56. Savli H, Sunnetci D, Cine N, Gluzman DF, Zavelevich MP, et al. (2012) Gene expression profiling of B-CLL in Ukrainian patients in post-Chernobyl period. Exp Oncol 34: 57-63.
57. Bast BJ, Zhou LJ, Freeman GJ, Colley KJ, Ernst TJ, et al. (1992) The HB-6, CDw75, and CD76 differentiation antigens are unique cell-surface carbohydrate determinants generated by the beta-galactoside alpha 2,6-sialyltransferase. J Cell Biol 116: 423-435.
58. Swindall AF, Bellis SL (2011) Sialylation of the Fas death receptor by ST6Gal-I provides protection against Fas-mediated apoptosis in colon carcinoma cells. J Biol Chem 286: 22982-22990.
59. Muppidi JR, Siegel RM (2004) Ligand-independent redistribution of Fas (CD95) into lipid rafts mediates clonotypic T cell death. Nat Immunol 5: 182-189.
60. Legembre P, Daburon S, Moreau P, Moreau JF, Taupin JL (2006) Modulation of Fas-mediated apoptosis by lipid rafts in T lymphocytes. J Immunol 176: 716-720.
61. Acquaviva J, Wong R, Charest A (2009) The multifaceted roles of the receptor tyrosine kinase ROS in development and cancer. Biochim Biophys Acta 1795: 37-52.
62. Rikova K, Guo A, Zeng Q, Possemato A, Yu J, et al. (2007) Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. Cell 131: 1190-1203.
63. Badve S, Deshpande C, Hua Z, Lögdberg L (2002) Expression of invariant chain (CD 74) and major histocompatibility complex (MHC) class II antigens in the human fetus. J Histochem Cytochem 50: 473-482.
64. Rocha N, Neefjes J (2008) MHC class II molecules on the move for successful antigen presentation. EMBO J 27: 1-5.
65. Taylor M, Hussain A, Urayama K, Chokkalingam A, Thompson P, et al. (2009) The human major histocompatibility complex and childhood leukemia: an etiological hypothesis based on molecular mimicry. Blood Cells Mol Dis 42: 129-135.
66. Vallat L, Magdelénat H, Merle-Béral H, Masdehors P, Potocki de Montalk G, et al. (2003) The resistance of B-CLL cells to DNA damage-induced apoptosis defined by DNA microarrays. Blood 101: 4598-4606.
67. Slager SL, Rabe KG, Achenbach SJ, Vachon CM, Goldin LR, et al. (2011) Genome-wide association study identifies a novel susceptibility locus at 6p21.3 among familial CLL. Blood 117: 1911-1916.
68. Machulla HK, Müller LP, Schaaf A, Kujat G, Schönermarck U, et al. (2001) Association of chronic lymphocytic leukemia with specific alleles of the HLADR4: DR53:DQ8 haplotype in German patients. Int J Cancer 92: 203-207.
69. Orouji E, Tavakkol Afshari J, Badiee Z, Shirdel A, Alipour A (2012) Association between HLA-DQB1 gene and patients with acute lymphoblastic leukemia (ALL). Int J Hematol 95: 551-555.
70. Lévéille C, Castaigne JG, Charron D, Al-Daccak R (2002) MHC class II isotypespecific signaling complex on human B cells. Eur J Immunol 32: 2282-2291.
71. Frazer JK, Capra JD Immunoglobulins: structure and function. In: Paul WE (Ed) (1999) Fundamental Immunology. Philadelphia: Lippincott-Raven.
72. Stevenson FK, Spellerberg M, Smith JL (1983) Monoclonal immunoglobulin light chain in urine of patients with B lymphocytic disease: its source and use as a diagnostic aid. Br J Cancer 47: 607-612.
73. Pratt G, Harding S, Holder R, Fegan C, Pepper C, et al. (2009) Abnormal serum free light chain ratios are associated with poor survival and may reflect biological subgroups in patients with chronic lymphocytic leukaemia. Br J Haematol 144: 217-222.
74. Brummer T, Elis W, Reth M, Huber M (2004) B-cell signal transduction: tyrosine phosphorylation, kinase activity, and calcium mobilization. Methods Mol Biol 271: 189-212.
75. Dal Porto JM, Gauld SB, Merrell KT, Mills D, Pugh-Bernard AE, et al. (2004) B cell antigen receptor signaling 101. Mol Immunol 41: 599-613.
76. Allen PB, Ouimet CC, Greengard P (1997) Spinophilin, a novel protein phosphatase 1 binding protein localized to dendritic spines. Proc Natl Acad Sci U S A 94: 9956-9961.
77. Hsieh-Wilson LC, Allen PB, Watanabe T, Nairn AC, Greengard P (1999) Characterization of the neuronal targeting protein spinophilin and its interactions with protein phosphatase-1. Biochemistry 38: 4365-4373.
78. Rubin E, Tamrakar S, Ludlow JW (1998) Protein phosphatase type 1, the product of the retinoblastoma susceptibility gene, and cell cycle control. Front Biosci 3: D1209-1219.
79. Li DW, Liu JP, Schmid PC, Schlosser R, Feng H, et al. (2006) Protein serine/ threonine phosphatase-1 dephosphorylates p53 at Ser-15 and Ser-37 to modulate its transcriptional and apoptotic activities. Oncogene 25: 3006-3022.
80. Vivo M, Calogero RA, Sansone F, Calabrò V, Parisi T, et al. (2001) The human tumor suppressor arf interacts with spinophilin/neurabin II, a type 1 proteinphosphatase-binding protein. J Biol Chem 276: 14161-14169.
81. Ferrer I, Blanco-Aparicio C, Peregrina S, Cañamero M, Fominaya J, et al. (2011) Spinophilin acts as a tumor suppressor by regulating Rb phosphorylation. Cell Cycle 10: 2751-2762.
82. Moffett S, Brown DA, Linder ME (2000) Lipid-dependent targeting of G proteins into rafts. J Biol Chem 275: 2191-2198.
83. Almazi JG, Mactier S, Best OG, Crossett B, Mulligan SP, et al. (2012) Fludarabine nucleoside induces accumulations of p53, p63 and p73 in the nuclei of human B-lymphoid cell lines, with cytosolic and mitochondrial increases in p53. Proteomics Clin Appl 6: 279-290.
84. Sargiacomo M, Sudol M, Tang Z, Lisanti MP (1993) Signal transducing molecules and glycosyl-phosphatidylinositol-linked proteins form a caveolinrich insoluble complex in MDCK cells. J Cell Biol 122: 789-807.
85. Shenoy-Scaria AM, Gauen LK, Kwong J, Shaw AS, Lublin DM (1993) Palmitylation of an amino-terminal cysteine motif of protein tyrosine kinases p56lck and p59fyn mediates interaction with glycosyl-phosphatidylinositolanchored proteins. Mol Cell Biol 13: 6385-6392.
86. Shaul PW, Smart EJ, Robinson LJ, German Z, Yuhanna IS, et al. (1996) Acylation targets emdothelial nitric-oxide synthase to plasmalemmal caveolae. J Biol Chem 271: 6518-6522.
87. Melkonian KA, Ostermeyer AG, Chen JZ, Roth MG, Brown DA (1999) Role of lipid modifications in targeting proteins to detergent-resistant membrane rafts. Many raft proteins are acylated, while few are prenylated. J Biol Chem 274: 3910-3917.
88. Lin HH, Han LY, Zhang HL, Zheng CJ, Xie B, et al. (2006) Prediction of the functional class of lipid binding proteins from sequence-derived properties irrespective of sequence similarity. J Lipid Res 47: 824-831.
89. Lemaire-Ewing S, Lagrost L, Néel D (2012) Lipid rafts: a signalling platform linking lipoprotein metabolism to atherogenesis. Atherosclerosis 221: 303-310.
90. Wang SH, Yuan SG, Peng DQ, Zhao SP (2010) High-density lipoprotein affects antigen presentation by interfering with lipid raft: a promising anti-atherogenic strategy. Clin Exp Immunol 160: 137-142.
91. Dell A, Morris HR (2001) Glycoprotein structure determination by mass spectrometry. Science 291: 2351-2356.
92. Parry S, Hanisch FG, Leir SH, Sutton-Smith M, Morris HR, et al. (2006) N-Glycosylation of the MUC1 mucin in epithelial cells and secretions. Glycobiology 16: 623-634.
93. Lee FA, van Lier M, Relou IA, Foley L, Akkerman JW, et al. (2006) Lipid rafts facilitate the interaction of PECAM-1 with the glycoprotein VI-FcR gammachain complex in human platelets. J Biol Chem 281: 39330-39338.
94. Vinson M, Rausch O, Maycox PR, Prinjha RK, Chapman D, et al. (2003) Lipid rafts mediate the interaction between myelin-associated glycoprotein (MAG) on myelin and MAG-receptors on neurons. Mol Cell Neurosci 22: 344-352.